Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global NK Cell Therapy Market Size Analysis from 2022 to 2027

1.5.1 Global NK Cell Therapy Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global NK Cell Therapy Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global NK Cell Therapy Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: NK Cell Therapy Industry Impact

Chapter 2 Global NK Cell Therapy Competition by Types, Applications, and Top Regions and Countries

2.1 Global NK Cell Therapy (Volume and Value) by Type

2.1.1 Global NK Cell Therapy Consumption and Market Share by Type (2016-2021)

2.1.2 Global NK Cell Therapy Revenue and Market Share by Type (2016-2021)

2.2 Global NK Cell Therapy (Volume and Value) by Application

2.2.1 Global NK Cell Therapy Consumption and Market Share by Application (2016-2021)

2.2.2 Global NK Cell Therapy Revenue and Market Share by Application (2016-2021)

2.3 Global NK Cell Therapy (Volume and Value) by Regions

2.3.1 Global NK Cell Therapy Consumption and Market Share by Regions (2016-2021)

2.3.2 Global NK Cell Therapy Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global NK Cell Therapy Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global NK Cell Therapy Consumption by Regions (2016-2021)

4.2 North America NK Cell Therapy Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia NK Cell Therapy Sales, Consumption, Export, Import (2016-2021)

4.4 Europe NK Cell Therapy Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia NK Cell Therapy Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia NK Cell Therapy Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East NK Cell Therapy Sales, Consumption, Export, Import (2016-2021)

4.8 Africa NK Cell Therapy Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania NK Cell Therapy Sales, Consumption, Export, Import (2016-2021)

4.10 South America NK Cell Therapy Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America NK Cell Therapy Market Analysis

5.1 North America NK Cell Therapy Consumption and Value Analysis

5.1.1 North America NK Cell Therapy Market Under COVID-19

5.2 North America NK Cell Therapy Consumption Volume by Types

5.3 North America NK Cell Therapy Consumption Structure by Application

5.4 North America NK Cell Therapy Consumption by Top Countries

5.4.1 United States NK Cell Therapy Consumption Volume from 2016 to 2021

5.4.2 Canada NK Cell Therapy Consumption Volume from 2016 to 2021

5.4.3 Mexico NK Cell Therapy Consumption Volume from 2016 to 2021

Chapter 6 East Asia NK Cell Therapy Market Analysis

6.1 East Asia NK Cell Therapy Consumption and Value Analysis

6.1.1 East Asia NK Cell Therapy Market Under COVID-19

6.2 East Asia NK Cell Therapy Consumption Volume by Types

6.3 East Asia NK Cell Therapy Consumption Structure by Application

6.4 East Asia NK Cell Therapy Consumption by Top Countries

6.4.1 China NK Cell Therapy Consumption Volume from 2016 to 2021

6.4.2 Japan NK Cell Therapy Consumption Volume from 2016 to 2021

6.4.3 South Korea NK Cell Therapy Consumption Volume from 2016 to 2021

Chapter 7 Europe NK Cell Therapy Market Analysis

7.1 Europe NK Cell Therapy Consumption and Value Analysis

7.1.1 Europe NK Cell Therapy Market Under COVID-19

7.2 Europe NK Cell Therapy Consumption Volume by Types

7.3 Europe NK Cell Therapy Consumption Structure by Application

7.4 Europe NK Cell Therapy Consumption by Top Countries

7.4.1 Germany NK Cell Therapy Consumption Volume from 2016 to 2021

7.4.2 UK NK Cell Therapy Consumption Volume from 2016 to 2021

7.4.3 France NK Cell Therapy Consumption Volume from 2016 to 2021

7.4.4 Italy NK Cell Therapy Consumption Volume from 2016 to 2021

7.4.5 Russia NK Cell Therapy Consumption Volume from 2016 to 2021

7.4.6 Spain NK Cell Therapy Consumption Volume from 2016 to 2021

7.4.7 Netherlands NK Cell Therapy Consumption Volume from 2016 to 2021

7.4.8 Switzerland NK Cell Therapy Consumption Volume from 2016 to 2021

7.4.9 Poland NK Cell Therapy Consumption Volume from 2016 to 2021

Chapter 8 South Asia NK Cell Therapy Market Analysis

8.1 South Asia NK Cell Therapy Consumption and Value Analysis

8.1.1 South Asia NK Cell Therapy Market Under COVID-19

8.2 South Asia NK Cell Therapy Consumption Volume by Types

8.3 South Asia NK Cell Therapy Consumption Structure by Application

8.4 South Asia NK Cell Therapy Consumption by Top Countries

8.4.1 India NK Cell Therapy Consumption Volume from 2016 to 2021

8.4.2 Pakistan NK Cell Therapy Consumption Volume from 2016 to 2021

8.4.3 Bangladesh NK Cell Therapy Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia NK Cell Therapy Market Analysis

9.1 Southeast Asia NK Cell Therapy Consumption and Value Analysis

9.1.1 Southeast Asia NK Cell Therapy Market Under COVID-19

9.2 Southeast Asia NK Cell Therapy Consumption Volume by Types

9.3 Southeast Asia NK Cell Therapy Consumption Structure by Application

9.4 Southeast Asia NK Cell Therapy Consumption by Top Countries

9.4.1 Indonesia NK Cell Therapy Consumption Volume from 2016 to 2021

9.4.2 Thailand NK Cell Therapy Consumption Volume from 2016 to 2021

9.4.3 Singapore NK Cell Therapy Consumption Volume from 2016 to 2021

9.4.4 Malaysia NK Cell Therapy Consumption Volume from 2016 to 2021

9.4.5 Philippines NK Cell Therapy Consumption Volume from 2016 to 2021

9.4.6 Vietnam NK Cell Therapy Consumption Volume from 2016 to 2021

9.4.7 Myanmar NK Cell Therapy Consumption Volume from 2016 to 2021

Chapter 10 Middle East NK Cell Therapy Market Analysis

10.1 Middle East NK Cell Therapy Consumption and Value Analysis

10.1.1 Middle East NK Cell Therapy Market Under COVID-19

10.2 Middle East NK Cell Therapy Consumption Volume by Types

10.3 Middle East NK Cell Therapy Consumption Structure by Application

10.4 Middle East NK Cell Therapy Consumption by Top Countries

10.4.1 Turkey NK Cell Therapy Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia NK Cell Therapy Consumption Volume from 2016 to 2021

10.4.3 Iran NK Cell Therapy Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates NK Cell Therapy Consumption Volume from 2016 to 2021

10.4.5 Israel NK Cell Therapy Consumption Volume from 2016 to 2021

10.4.6 Iraq NK Cell Therapy Consumption Volume from 2016 to 2021

10.4.7 Qatar NK Cell Therapy Consumption Volume from 2016 to 2021

10.4.8 Kuwait NK Cell Therapy Consumption Volume from 2016 to 2021

10.4.9 Oman NK Cell Therapy Consumption Volume from 2016 to 2021

Chapter 11 Africa NK Cell Therapy Market Analysis

11.1 Africa NK Cell Therapy Consumption and Value Analysis

11.1.1 Africa NK Cell Therapy Market Under COVID-19

11.2 Africa NK Cell Therapy Consumption Volume by Types

11.3 Africa NK Cell Therapy Consumption Structure by Application

11.4 Africa NK Cell Therapy Consumption by Top Countries

11.4.1 Nigeria NK Cell Therapy Consumption Volume from 2016 to 2021

11.4.2 South Africa NK Cell Therapy Consumption Volume from 2016 to 2021

11.4.3 Egypt NK Cell Therapy Consumption Volume from 2016 to 2021

11.4.4 Algeria NK Cell Therapy Consumption Volume from 2016 to 2021

11.4.5 Morocco NK Cell Therapy Consumption Volume from 2016 to 2021

Chapter 12 Oceania NK Cell Therapy Market Analysis

12.1 Oceania NK Cell Therapy Consumption and Value Analysis

12.2 Oceania NK Cell Therapy Consumption Volume by Types

12.3 Oceania NK Cell Therapy Consumption Structure by Application

12.4 Oceania NK Cell Therapy Consumption by Top Countries

12.4.1 Australia NK Cell Therapy Consumption Volume from 2016 to 2021

12.4.2 New Zealand NK Cell Therapy Consumption Volume from 2016 to 2021

Chapter 13 South America NK Cell Therapy Market Analysis

13.1 South America NK Cell Therapy Consumption and Value Analysis

13.1.1 South America NK Cell Therapy Market Under COVID-19

13.2 South America NK Cell Therapy Consumption Volume by Types

13.3 South America NK Cell Therapy Consumption Structure by Application

13.4 South America NK Cell Therapy Consumption Volume by Major Countries

13.4.1 Brazil NK Cell Therapy Consumption Volume from 2016 to 2021

13.4.2 Argentina NK Cell Therapy Consumption Volume from 2016 to 2021

13.4.3 Columbia NK Cell Therapy Consumption Volume from 2016 to 2021

13.4.4 Chile NK Cell Therapy Consumption Volume from 2016 to 2021

13.4.5 Venezuela NK Cell Therapy Consumption Volume from 2016 to 2021

13.4.6 Peru NK Cell Therapy Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico NK Cell Therapy Consumption Volume from 2016 to 2021

13.4.8 Ecuador NK Cell Therapy Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in NK Cell Therapy Business

14.1 Nektar Therapeutics

14.1.1 Nektar Therapeutics Company Profile

14.1.2 Nektar Therapeutics NK Cell Therapy Product Specification

14.1.3 Nektar Therapeutics NK Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 Kiadis Pharma

14.2.1 Kiadis Pharma Company Profile

14.2.2 Kiadis Pharma NK Cell Therapy Product Specification

14.2.3 Kiadis Pharma NK Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 Chipscreen Biosciences

14.3.1 Chipscreen Biosciences Company Profile

14.3.2 Chipscreen Biosciences NK Cell Therapy Product Specification

14.3.3 Chipscreen Biosciences NK Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Innate Pharma SA

14.4.1 Innate Pharma SA Company Profile

14.4.2 Innate Pharma SA NK Cell Therapy Product Specification

14.4.3 Innate Pharma SA NK Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 Dragonfly Therapeutics

14.5.1 Dragonfly Therapeutics Company Profile

14.5.2 Dragonfly Therapeutics NK Cell Therapy Product Specification

14.5.3 Dragonfly Therapeutics NK Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 Affimed

14.6.1 Affimed Company Profile

14.6.2 Affimed NK Cell Therapy Product Specification

14.6.3 Affimed NK Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 Nkarta Therapeutics

14.7.1 Nkarta Therapeutics Company Profile

14.7.2 Nkarta Therapeutics NK Cell Therapy Product Specification

14.7.3 Nkarta Therapeutics NK Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 Glycostem Therapeutics

14.8.1 Glycostem Therapeutics Company Profile

14.8.2 Glycostem Therapeutics NK Cell Therapy Product Specification

14.8.3 Glycostem Therapeutics NK Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.9 Fate Therapeutics

14.9.1 Fate Therapeutics Company Profile

14.9.2 Fate Therapeutics NK Cell Therapy Product Specification

14.9.3 Fate Therapeutics NK Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.10 NantWorks

14.10.1 NantWorks Company Profile

14.10.2 NantWorks NK Cell Therapy Product Specification

14.10.3 NantWorks NK Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.11 Fortress Biotech

14.11.1 Fortress Biotech Company Profile

14.11.2 Fortress Biotech NK Cell Therapy Product Specification

14.11.3 Fortress Biotech NK Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global NK Cell Therapy Market Forecast (2022-2027)

15.1 Global NK Cell Therapy Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global NK Cell Therapy Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global NK Cell Therapy Value and Growth Rate Forecast (2022-2027)

15.2 Global NK Cell Therapy Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global NK Cell Therapy Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global NK Cell Therapy Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America NK Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia NK Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe NK Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia NK Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia NK Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East NK Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa NK Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania NK Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America NK Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global NK Cell Therapy Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global NK Cell Therapy Consumption Forecast by Type (2022-2027)

15.3.2 Global NK Cell Therapy Revenue Forecast by Type (2022-2027)

15.3.3 Global NK Cell Therapy Price Forecast by Type (2022-2027)

15.4 Global NK Cell Therapy Consumption Volume Forecast by Application (2022-2027)

15.5 NK Cell Therapy Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology